Table 4 Effects of various risk factors on hyperkalemia occurrence in 3,732 infants who were born at 32–36 gestational weeks.
Risk factorsa | Univariate analysis | Multivariable analysisb | ||||
|---|---|---|---|---|---|---|
Crude odds ratio (95% CI) | P-value | Adjusted odds ratio (95% CI) | P-value | |||
Combination of MgSO4 and ritodrine | ||||||
MgSO4 alone vs. no usage | 0.87 | (0.47–1.61) | 0.654 | 0.63 | (0.33–1.20) | 0.155 |
Ritodrine alone vs. no usage | 1.19 | (0.90–1.59) | 0.224 | 1.20 | (0.89–1.62) | 0.231 |
Both MgSO4 and ritodrine vs. no usage | 1.78 | (1.29–2.45) | <0.001 | 1.53 | (1.09–2.15) | 0.015 |
Obstetrical complications | ||||||
pPROM | 0.78 | (0.58–1.04) | 0.085 | 0.78 | (0.57–1.07) | 0.118 |
GH/PE/eclampsia/HELLP/AFLP | 1.21 | (0.89–1.65) | 0.232 | 1.37 | (0.96–1.96) | 0.085 |
Placental abruption | 0.60 | (0.26–1.38) | 0.233 | 0.46 | (0.19–1.09) | 0.076 |
Placenta previa/Low lying placenta | 1.33 | (0.85–2.09) | 0.210 | 1.24 | (0.76–2.02) | 0.389 |
DM | 0.64 | (0.15–2.65) | 0.535 | 0.85 | (0.20–3.56) | 0.818 |
GDM | 1.53 | (0.94–2.47) | 0.085 | 1.63 | (0.998–2.67) | 0.051 |
Cesarean section | 1.13 | (0.87–1.47) | 0.354 | 0.96 | (0.71–1.31) | 0.798 |
Delivery at <35 wk | 1.45 | (1.14–1.85) | 0.003 | 1.46 | (1.13–1.88) | 0.004 |
Twins/triplets | 1.15 | (0.88–1.49) | 0.303 | 1.11 | (0.82–1.50) | 0.501 |
Sex: male | 0.91 | (0.71–1.16) | 0.994 | 0.92 | (0.72–1.18) | 0.511 |
SGA infants | 0.88 | (0.61–1.27) | 0.496 | 0.87 | (0.59–1.28) | 0.477 |
Large-for-gestational-age infants | 0.37 | (0.05–2.68) | 0.323 | 0.35 | (0.05–2.61) | 0.306 |
Apgar score at 1 min < 3 | 2.01 | (1.21–3.36) | 0.008 | 2.21 | (1.29–3.81) | 0.004 |